Resources
On the Edge of Dermatology Early Phase Trials
Watch this exciting webinar presented by Innovaderm Research in collaboration with Altasciences and be part of: Deep Dive in Study Design Discussion on SAD-MAD-POC Best Practices and Innovations From our early phase experts: Dr. Ana Palijan, Associate Director, Early Phase Department, Innovaderm Research Dr. Beatrice Setnik, Chief Scientific Officer, Altasciences Fareheen Chowdhury, Project Manager, Early […]
Conducting a Successful Medical Aesthetic Trial—Expert Strategies
The medical aesthetic market presents itself as a dynamic frontier with immense possibilities. Site selection, patient enrollment optimization, proper collection of relevant data, and proper operationalization set up, all have a direct influence on the progress of a medical aesthetic trial. Thus, closely exploring these key components will maximize a trial’s success.
Strategies for Effective Clinical Site Management
The successful management of a clinical trial is a fine balance between multiple significant elements; rather it is the feasibility aspect, patient recruitment, optimized protocol, etc. The relationship with the clinical research site is often a point that goes unnoticed. Clinical research sites are integral to the success of clinical trials and the pathway to this success begins with maintaining positive professional rapports between sites and CROs. Fostering this kinship will be paramount to the overall flow of your trial as well as for future site collaborations, expediency and efficiency of the study start-up, facilitated budget and contract negotiations and, overall streamed line activation process.
Unlocking the Market Potential of Medical Aesthetics
The medical aesthetics industry is an increasingly lucrative and rapidly developing sector of healthcare, currently valued at $13.9 billion and expected to reach a total of $23.4 billion by 2027. Despite this enticing profit potential, developers must consider the numerous challenges and emerging trends that will shape the future of this market.
Developing Dermal Fillers and Neuromodulators for Aesthetic Indications
Dermal fillers, also known as injectable implants, soft tissue fillers, or wrinkle fillers have been on the medical aesthetic market for over 30 years and have a variety of specific technological characteristics and indications. The successful conduct of a medical aesthetic clinical trial is dependent upon the development of an optimal study protocol, meticulous planning, and diligent implementation. The key protocol considerations for development of dermal fillers are detailed below.
Enhancing the Quality of Clinical Trial Data With 3D Photography
As the medical aesthetic market experiences robust growth, its accompanying technologies continue to evolve. Aesthetic trials use validated scales to evaluate the severity and improvement of a given condition in order to support efficacy endpoints. These evaluations are often performed as live local assessments at the site. However, as objective as these scales aim to be, these methods of assessment often lack standardization and introduce biases that can affect the reliability of the final results.
In-Person Breakfast Event at the AAD - Spotlight on Hidradenitis Suppurativa
Innovaderm was in New Orleans for the 2023 edition of the AAD congress and hosted its 4th Breakfast Event: Spotlight on Hidradenitis Suppurativa (HS). Listen to our world-renowned dermatology key opinion leaders' presentations to learn about HS and the latest research findings: Dr. Amit Garg, MD - Challenges of Current Scales & Development of Novel […]
Generalized Pustular Psoriasis (GPP) Rescue Case Study
Click here for a PDF version of this case study Outcomes Innovaderm successfully transitioned this rescue study from another CRO and this resulted in: More than doubled patient enrollment in 1 month Started enrollment 1 month faster than initial projection All 5 newly added sites were actively recruiting Study Characteristics Study Phase: IIa Study […]
3 Tips for Collecting Samples with Tape Stripping
Tape Stripping is a non-invasive option for the study of biomarkers in dermatology studies. Innovaderm is sharing its 3 best tips when performing tape strip collections. Let’s cover our bases, what is tape stripping? Tape stripping is used in dermatology studies to sample skin surface material by collecting a thin layer of cells from the […]
Centralized Monitoring: Exploring the Considerations and Challenges of Implementation
Innovaderm's Associate Director - Risk Based Quality Management, Rohit Gupta, contributed to PHUSE's white paper entitled: “Centralized Monitoring: Exploring the Considerations and Challenges of Implementation”. Innovaderm is proud to have been involved in the development of such a document addressing: 1. The key success measures & best practices to ensure a well-connected end-to-end component of […]
3 Tips on How to Manage Rosacea Trials
April is dedicated to raising awareness around Rosacea. One of Innovaderm’s all-star project managers, Nalanie Johnson, shared some tips that are crucial when managing a clinical trial to the complexity of a therapeutic indication such as Rosacea: 1. In managing Rosacea studies, it is important to understand the indication and patient flow. Most patients will […]
Hidradenitis Suppurativa (HS) Case study
Click here for a PDF version of this case study Outcomes Innovaderm successfully managed this HS study and this resulted in: Enrollment completed 3 months ahead of schedule Study Characteristics Study Phase: II Patient Population: Hidradenitis Suppurativa IP Route of Administration: Systemic - Subcutaneous Site distribution: 25 in North America and 16 in Europe […]
Clinical Trials Information System (CTIS)
📣Attention all clinical trial sponsors who are planning to conduct a study in the EU or EEA! Beginning on January 31, 2023, the Clinical Trials Information System (CTIS) must be used to submit any new clinical trial application in these regions. This new process permits a single application to secure authorizations in up to 30 […]
Palmoplantar Pustulosis (PPP) Case Study
Click here for a PDF version of this case study Outcomes Innovaderm successfully managed this PPP study and this resulted in: Enrollment completed 3 weeks ahead of schedule; Successful study and satisfied sponsor Study Characteristics Study Phase: II Patient Population: Palmoplantar pustulosis IP Route of Administration: Systemic Sites Distribution: 17 sites in 2 countries […]
Tips For a Successful Study in Medical Aesthetics
Watch this exciting and informative webinar about best practices on medical aesthetic studies from our industry experts. You will learn about: Insight into industry trends and key study design considerations; How to execute studies quickly without compromising data quality; Benefits and limits of qualitative image-derived evaluations From our industry Experts: Jasmina Jankicevic, Chief Medical Officer, […]
Notalgia Paresthetica (NP) Case Study
Click here for a PDF version of this case study Study Characteristics Study Phase: II Patient Population: 126 patients with Notalgia Paresthetica (NP) (Pruritus associated with NP) IP Route of Administration: Systemic (oral) Site Distribution: 33 sites (USA and Canada) Study Procedures: Photographs, Pharmacokinetics, Electrocardiograms Study Challenges Patient awareness: Challenge in advertisement as […]
Non-invasive methods to study molecular biomarkers in the skin: Tape Stripping and Beyond
Please join us for this unique webinar to learn more about non-invasive methods to collect and evaluate skin biomarkers in clinical trials. You will learn more about: Tape stripping techniques Sensitivity of various cutaneous biomarkers Non-invasive sample collection methods for skin protein and RNA analysis Questions? Contact us Newsletter Get notified to have […]
Alopecia Areata (AA) Case Study
Click here for a PDF version of this case study Outcomes Innovaderm’s outstanding support on this alopecia areata study resulted in a rapid increase in enrollment rates and the successful management of this trial Study Characteristics Study Phase: II Patient Population: Alopecia Areata IP Route of Administration: Systemic Sites distribution: 12 sites (CAD-USA) Complex […]
Atopic Dermatitis (AD) Case Study
Click here for a PDF version of this case study Outcomes Innovaderm successfully managed this AD study and this resulted in: Enrollment completed 2 months earlier than planned; Innovaderm CRU recruited 33% of patients Study Characteristics Study Phase: Ib Patient Population: 36 subjects with moderate to severe AD IP Route of Administration: Systemic - […]
Acne Case Study
Click here for a PDF version of this case study Outcomes Innovaderm successfully managed this acne study and this resulted in: Enrollment completed 1 month earlier than planned Study Characteristics Study Phase: II Patient Population: Acne vulgaris (enrolling pediatrics & adults) IP Route of Administration: Systemic Sites distribution: 15 sites (USA) Study […]
Palmoplantar Pustulosis (PPP) Rescue Case Study
Click here for a PDF version of this case study Outcomes Innovaderm successfully transitioned this rescue study from another CRO and this resulted in: Increase in enrollment of over 10x Tripled site performance post transition On-time patient recruitment Study Characteristics Study Phase: II Study Status: Rescue study Patient Population: Palmoplantar pustulosis (PPP) IP Route […]
Skin Barrier Dysfunction: Atopic Dermatitis and Beyond
Don't miss this opportunity to join us for an informative session on skin barrier dysfunction where you will learn about: The disorder and its role in atopic dermatitis The impact of immune dysregulations and microbiome abnormalities on inherent skin barrier anomalies Methods to study skin barrier integrity in clinical trials Questions? Contact us Newsletter […]
How to Write First-Rate Protocols for an Atopic Dermatitis Study - Focus: CLINICAL ASSESSMENTS AND ENDPOINTS
In recent years, therapeutics for dermatologic conditions have become a subspecialty of growing interest in the Clinical Research Organisation (CRO) industry, with clinical research in the area focused on a wide range of skin indications, such as acne vulgaris, psoriasis, and atopic dermatitis. What is atopic dermatitis? Atopic dermatitis (AD), also known as atopic eczema, […]
How to Write First-Rate Protocols for an Atopic Dermatitis Study - Focus: TREATMENT DURATION AND KEY ELIGIBILITY CRITERIA
In recent years, therapeutics for dermatologic conditions have become a subspecialty of growing interest in the Clinical Research Organisation (CRO) industry, with clinical research in the area focused on a wide range of skin indications, such as acne vulgaris, psoriasis, and atopic dermatitis. What is atopic dermatitis? Atopic dermatitis (AD), also known as atopic eczema, […]
How to Write First-Rate Protocols for an Atopic Dermatitis Study - Focus: STUDY DESIGN
n recent years, dermatologic therapeutics has become a subspecialty of growing interest in the CRO industry, with clinical research in the area focused on a wide range of skin indications such as acne vulgaris, psoriasis, and atopic dermatitis.
The Art of Protocol Writing in Dermatology
Watch this exciting and informative webinar on how to write the best protocols in dermatology. You will learn about: protocol development and associated tools; protocol considerations for key dermatology indications; clinical assessments, eligibility criteria, study design and more! Questions? Contact us Newsletter Get notified to have the latest trends and be at the […]
How to Handle Missing Data in Dermatology Trials
Watch this unique webinar to learn more about how to handle missing data in dermatology trials. You will learn more about: How missing data arises in dermatology studies Which statistical methods to choose to deal with missing data Which methods may be preferred by the Regulatory Bodies Questions? Contact us Newsletter Get notified to […]
